At around the 17:30 mark of the CC, with respect to the P2 CRC trial, the CEO states there is "interesting data" that ARQL wants to make available and that ASCO is the first window for the data.
Golly... what a surprise! -g- (Actually the only surprise is that they now say they will have data by ASCO - which is earlier than they had previously stated.)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.